Table 2. Glucose metabolism disorders (GMD) among 454 study participants.

Variable	HIV-negative Control (n = 153)	HIV-infected ART-naïve (n = 151)	p-value vs. control	HIV-infected on ART (n = 150)	p-value vs. control
	Proportion (%) Median (IQR)	Proportion (%) Median (IQR)		Proportion (%) Median (IQR)
Any GMD *	11 (7.2%)	12 (8.0%)	0.83	49 (32.7%)	<0.001
Diabetes mellitus	8 (5.2%)	1 (0.7%)	0.04	27 (18.0%)	0.001
Impaired fasting glucose	0	5 (3.3%)	0.03	1 (0.7%)	0.50
Impaired glucose tolerance	3 (2.0%)	6 (4.0%)	0.33	21 (14.0%)	<0.001
Fasting blood glucose (mmol/L)	4.7 (4–5)	4.7 (4–5.1)	0.55	5.6 (4.8–6)	<0.0001
2-hour blood glucose (mmol/L)	5.6 (5–6)	5.5 (5–6.1)	0.41	6.6 (5.8–8.1)	<0.0001

* Primary outcome: defined as either Diabetes Mellitus or Impaired Fasting Glucose or Impaired Glucose Tolerance